POC5 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.769000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.735000E-01
Normal-vs-Stage2
2.627400E-01
Normal-vs-Stage3
5.625800E-02
Normal-vs-Stage4
2.325400E-01
Stage1-vs-Stage2
6.959800E-02
Stage1-vs-Stage3
2.379900E-02
Stage1-vs-Stage4
4.998200E-01
Stage2-vs-Stage3
5.385700E-02
Stage2-vs-Stage4
5.746800E-01
Stage3-vs-Stage4
1.238010E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.761600E-03
Normal-vs-AfricanAmerican
2.526200E-01
Normal-vs-Asian
1.816430E-02
Caucasian-vs-AfricanAmerican
6.374000E-01
Caucasian-vs-Asian
1.440780E-01
AfricanAmerican-vs-Asian
5.349200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.001600E-02
Normal-vs-Female
2.601200E-01
Male-vs-Female
2.970400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.911800E-01
Normal-vs-Age(41-60Yrs)
1.770150E-02
Normal-vs-Age(61-80Yrs)
4.961900E-03
Normal-vs-Age(81-100Yrs)
2.694800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.748800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.051400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.053200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.999000E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.319000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.236200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.306600E-01
Normal-vs-Daily Drinker
7.046200E-02
Normal-vs-Weekly Drinker
2.020200E-01
Normal-vs-Occasional Drinker
6.383700E-02
Normal-vs-Social Drinker
2.853400E-01
Non Drinker-vs-Daily Drinker
1.060630E-01
Non Drinker-vs-Weekly Drinker
4.851200E-01
Non Drinker-vs-Occasional Drinker
1.118400E-01
Non Drinker-vs-Social Drinker
2.805400E-01
Daily Drinker-vs-Weekly Drinker
6.140100E-02
Daily Drinker-vs-Occasional Drinker
9.945200E-01
Daily Drinker-vs-Social Drinker
5.296000E-01
Weekly Drinker-vs-Occasional Drinker
5.572200E-02
Weekly Drinker-vs-Social Drinker
7.810300E-02
Occasional Drinker-vs-Social Drinker
5.572600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.791000E-01
Normal-vs-Grade 2
5.291800E-01
Normal-vs-Grade 3
5.490300E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.032800E-01
Grade 1-vs-Grade 3
4.954600E-01
Grade 1-vs-Grade 4
2.791000E-01
Grade 2-vs-Grade 3
7.459400E-01
Grade 2-vs-Grade 4
5.291800E-01
Grade 3-vs-Grade 4
5.490300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.182020E-02
Normal-vs-NonDiabetic
6.075500E-03
Diabetic-vs-NonDiabetic
8.268200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.442800E-01
Normal-vs-NoPancreatitis
5.583100E-03
Pancreatitis-vs-NoPancreatitis
5.430000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.568100E-02
Normal-vs-N1
2.583200E-01
N0-vs-N1
1.980560E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.573600E-01
Normal-vs-TP53-NonMutant
1.240150E-01
TP53-Mutant-vs-TP53-NonMutant
3.295400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
